Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis

NCT02062216 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-03-14

No results posted yet for this study

Summary

The primary objective of this study is to assess whether inflammatory receptors play a role in the pathogenesis of atherosclerosis.

Conditions

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-12-31
Completion
2018-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062216 on ClinicalTrials.gov